Related references
Note: Only part of the references are listed.Unauthorized ingredients in nootropic dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents
Karol Jedrejko et al.
DRUG TESTING AND ANALYSIS (2023)
The unapproved drug centrophenoxine (meclofenoxate) in cognitive enhancement dietary supplements
Pieter A. Cohen et al.
CLINICAL TOXICOLOGY (2022)
Chromatographic-mass spectrometric analysis of the urinary metabolite profile of chlorphenesin observed after dermal application of chlorphenesin-containing sunscreen
Ana Rubio et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2021)
Safety Assessment of Chlorphenesin as Used in Cosmetics
Wilbur Johnson et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2014)
A Simple and Sensitive HPLC Method For Quantification of the Metabolin of Meclofenoxate In Human Plasma
Bin Ni et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2010)
Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)
J. R. Docherty
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Bioequivalence and Pharmacokinetic Comparison of a Single 200-mg Dose of Meclofenoxate Hydrochloride Capsule and Tablet Formulations in Healthy Chinese Adult Male Volunteers: A Randomized Sequence, Open-Label, Two-Period Crossover Study
Jian-Jun Zou et al.
CLINICAL THERAPEUTICS (2008)